CLINICAL_TRIALS
trial_result
· 2021-06-03
Clinical Trial Update: Osimertinib Study in Indian Patients [Phase 4]
Summary
Phase 4 trial update of osimertinib in Indian patients with non-small cell lung cancer has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Non Small Cell Lung Cancer (NSCLC) | Phase 4 | Status: COMPLETED | Results posted: 2021-06-03